Drug ID:Drug105
Drug Name:Probiotic
CID:6713928
DrugBank ID:NULL
Modality:Small Molecule
Groups:NULL
US Approved:NULL
Other Approved:NULL
Identifier: NCT01479660, , NCT01765998, , NCT00161148, , NCT04223479
Molecular Formula:C17H19N3O4S
Molecular Weight:361.4 g/mol
Isomeric SMILES:CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=C)C(=O)O)C
Synonyms:metampicillin; 6489-97-0; Micinovo; Viderpen; Ruticina; methylenampicillin; fedacilina; pravacilin; Metampicilina; Metampicilline
Phase 0: 0
Phase 1: 0
Phase 2: 0
Phase 3: 0
Phase 4: 0
Description:NULL

Molecular Structure

2D Molecular Structure

Knowledge Graph

dtIDCIDCompound NameGene IDGene NameSpeciesPubMed IDsAction
No data available

  • No data available

Phase Distribution
Phase Description
  • Phase 0: Exploratory trials to assess drug behavior in humans
  • Phase 1: Safety trials to determine safe dosage range
  • Phase 2: Efficacy trials to evaluate therapeutic effects
  • Phase 3: Large-scale trials to confirm efficacy and safety
  • Phase 4: Post-marketing surveillance for long-term safety and efficacy

Trial IDTitlePhaseStatusSponsorIndicationsInterventions
NCT04006977 Multistrain Probiotics Reduces UC Depression and Anxiety Scores None UNKNOWN Xijing Hospital of Digestive Diseases Ulcerative Colitis DIETARY_SUPPLEMENT: a multistrain probiotic produ… Details
NCT04969679 Additive Effect of Probiotics (Mutaflor) in Patients With Ulcerative Colitis on 5-ASA Treatment. PHASE4 COMPLETED Kangbuk Samsung Hospital Ulcerative Colitis DRUG: E. coli Nissle 1917 (Mutaflor)|DRUG: Placebo Details
NCT04223479 Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan PHASE2|PHASE3 COMPLETED University of Jordan Ulcerative Colitis DRUG: Probiotic Formula Capsule|DRUG: Placebos Details
NCT06609447 The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis PHASE4 RECRUITING Second Affiliated Hospital, School of Medicine, Zhejiang University Ulcerative Colitis DIETARY_SUPPLEMENT: VSL#3|DIETARY_SUPPLEMENT: Pla… Details
NCT00374725 Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. None COMPLETED Odense University Hospital Ulcerative Colitis BEHAVIORAL: Administration of probiotic (L. rhamn… Details
NCT02361957 The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis Patients None SUSPENDED Wageningen University Ulcerative Colitis DIETARY_SUPPLEMENT: Ecologic 825|DIETARY_SUPPLEME… Details
NCT00161148 Probiotics in Patients With Primary Sclerosing Cholangitis PHASE3 UNKNOWN UMC Utrecht Primary Sclerosing Cholangitis DRUG: Probiotics Details
NCT03415711 PRObiotic VSL#3 for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis None TERMINATED VSL Pharmaceuticals Ulcerative Colitis DIETARY_SUPPLEMENT: VSL#3|DRUG: Mesalamine|DRUG: … Details
NCT06392061 Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease None RECRUITING Lebanese University Inflammatory Bowel Diseases|Quality of Life|Food … DIETARY_SUPPLEMENT: Trilac Details
NCT01632462 A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease PHASE4 UNKNOWN Federico II University Crohn's Disease DRUG: VSL#3 Details
NCT06781827 Application Research of Lactobacillus Reuteri in the Treatment of Inflammatory Bowel Not Available Recruiting Wecare Probiotics Co., Ltd. Inflammatory Bowel Disease Dietary Supplement: Probiotic;Dietary Supplement:… Details
ACTRN12623001315606 Do perioperative synbiotics reduce postoperative infectious complications in patients undergoing elective colorectal resection? Not Available Recruiting The University of Auckland Colorectal disease;Postoperative infection;Colore… The intervention is a synbiotic powder manufactur… Details
ACTRN12623000630617 The INHABIT (synergIstic effect of aNtHocyAnin and proBIoTics in) Inflammatory Bowel Disease Trial: A double-blind randomised controlled trial assessing faecal calprotectin, gut microbiota profile and quality-of-life. Not Available Recruiting University of Wollongong Mild-moderate Ulcerative Colitis ; Mild-moderate… A double-blind randomised controlled trial of 12 … Details
RBR-8js7t83 Use of a Lactobacillus rhamnosus formula as adjuvant in the treatment of plaque psoriasis patients Not Available Not Recruiting Enrico Stefano Suriano Psoriasis;C17.800 All included subjects were 18 years old or older,… Details
CTRI/2019/11/022087 A Study to Assess the Effect of a Probiotic Strains (Bacillus clausii) on Gut Microbiota and Mucosal Immunity in Inflammatory Bowel Disease - EPMIBD PHASE2 Recruiting Unique Biotech Health Condition 1: null- Inflammatory Bowel Dise… Intervention1: Casule of Bacillus clausii UBBC07(… Details
NL-OMON55158 A randomized controlled trial to investigate the efficacy of a multispecies probiotic supplement (Ecologic BARRIER) on symptoms of fatigue in subjects with Inflammatory Bowel Disease - Probiotics against fatigue in IBD Not Available Recruiting Elisabeth-Tweesteden ziekenhuis chronic bowel inflammation inflammatory bowel di… Group A will daily receive 4 grams (2,5*109 cfu/g… Details
ChiCTR1900026666 Clinical effect observation and Mechanism Discussion of low FODMAP diet combined with probiotics in the treatment of irritable bowel syndrome Not Available Recruiting West China Hospital, Sichuan University Inflammatory bowel disease Group 1:Low FODMAP diet;Group 2:Probiotic treatme… Details
NL-OMON40262 THE CUPIDO STUDY: __ The effect of the multispecies probiotic Ecologic 825 versus placebo in Ulcerative Colitis patients__ - CUPIDO study Not Available Not Recruiting Wageningen Universiteit inflammatory bowel disease (IBD) Ulcerative Coli… Patients will receive either two daily dosages of… Details
IRCT201105106431N1 Effects of probiotic yogurt ingestion on inflammation parameters, micro flora and intestinal permeability in patients with inflammatory bowel disease Not Available Not Recruiting Vice Chancellor for Research and Technology, Shahid Beheshti University of Medical Sciences Condition 1: Inflammatory bowel disease. Conditio… Intervention 1: Control group: non-probiotic yogu… Details
NCT03266484 Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease None UNKNOWN Massachusetts General Hospital Inflammatory Bowel Diseases|Crohn Disease|Ulcerat… DIETARY_SUPPLEMENT: Probiotic Mixture|DIETARY_SUP… Details

Disease IDDisease NameDefinitionCategoryRelated DrugsMechanism
No data available

Strategy IDTherapeutic StrategySynonymsRelated DrugsMechanism
S11 Improveming Intestinal Microecology the intestinal microbiota antibiotics; probiotics; prebiotics; postbiotics; synbiotics; fecal microbiota transplantation (FMT) The imbalance between beneficial bacteria and harmful patho… Details

No related literature

You can run management commands to establish drug-literature associations